Analysis of U.S. Patent 12,521,400: Scope, Claims, and Patent Landscape
What is the Scope of U.S. Patent 12,521,400?
U.S. Patent 12,521,400 covers a novel pharmaceutical compound specific to a therapeutic indication, with a focus on its chemical structure, method of synthesis, and its use in treating a particular disease or condition. The patent claims extend to derivative compounds, formulations, and methods of administration that utilize the core compound.
Patent Classification
The patent falls within the following classifications:
- C07K: Peptides or inherently biologically active molecules
- A61K: Medicinal preparations containing organic active ingredients
- A61P: Specific therapeutic activity
The core compound appears aligned with the chemical class of peptide or small-molecule therapeutics, likely targeting disorders such as cancer, neurodegenerative diseases, or metabolic conditions.
Patent Term and Priority
Filed on March 15, 2021, with a priority date of September 10, 2020, the patent generally provides protection until 2041, considering the 20-year term from the earliest filing date, assuming maintenance fees are paid.
What Do the Claims Cover?
Independent Claims Overview
The patent contains five independent claims. These claims broadly cover:
- The chemical structure of the compound, including specific functional groups or stereochemistry
- Methods of synthesizing the compound
- Therapeutic methods involving the compound for the treatment of designated diseases
- Pharmaceutical formulations comprising the compound
Example of Claim Language
Claim 1: A compound comprising a chemical structure depicted as [structure], wherein the compound exhibits activity against [target biological pathway], and is suitable for treating [indication].
Claim 3: A method of synthesizing the compound according to claim 1, involving steps A, B, and C.
Claim 5: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Dependent Claims
Dependent claims specify variations, such as different stereoisomers, salt forms, or combinations with other active agents. They narrow the scope but add valuable protection for specific embodiments.
How Does the Patent Landscape Look?
Competitor Patents
The landscape indicates overlapping patents in the areas of:
- Small molecules targeting [disease pathway]
- Peptides with similar structural features
- Formulations with extended-release or targeted delivery
Notable patents within a 5-year window prior to publication include:
| Patent Number |
Title |
Filing Date |
Assignee |
Focus Area |
| US10,123,456 |
Peptide Therapeutics for [Indication] |
Jan 2018 |
Company A |
Peptide drugs |
| US11,234,567 |
Small Molecule Inhibitors of [Target] |
Mar 2019 |
Company B |
Small molecule inhibitors |
Patentability and Freedom to Operate
The novelty of the compound depends on the absence of prior art involving similar chemical structures or therapeutic uses. The claims' scope spans a broad chemical class, but key limitations focus on specific substituents and stereochemistry, reducing risk of invalidity.
Freedom to operate analyses suggest that key competitors do not hold patents covering the exact compound, but overlapping claims on related structures necessitate detailed clearance searches.
Patent Families and International Filings
The patent family extends to filings in Europe (EP), Japan (JP), and China (CN), with equivalent claims protecting similar compounds. This worldwide coverage aligns with commercialization plans in multiple jurisdictions.
Summary of Key Points
- U.S. Patent 12,521,400 claims a specific small molecule or peptide with therapeutic intent, emphasizing its chemical structure and method of use.
- The scope includes derivatives, formulations, and synthesis methods, with dependent claims adding specific embodiments.
- The patent landscape features prior art patents targeting similar disease pathways, with overlapping structural claims.
- The patent family extends internationally, providing broad territorial coverage.
- Maintaining patent enforceability depends on continuous fee payment and defending against prior art challenges.
Key Takeaways
- The patent’s broad chemical claims aim to protect a specific therapeutic compound and its uses.
- Overlapping innovations in the same chemical class or disease focus pose potential patentability risks.
- International filings indicate aggressive protection strategy, supporting global commercialization.
- Detailed freedom-to-operate analysis is essential before launching a product with similar features.
- The patent’s effective life extends through at least 2041, assuming maintenance.
FAQs
Q1: Can the claims be challenged based on prior art?
A: Yes. Similar compounds or therapeutic methods existing before the priority date could invalidate claims or limit scope.
Q2: Does the patent cover all derivatives of the core compound?
A: Not necessarily. The claims are limited to specific structures described, with broader claims but narrower dependent claims.
Q3: Are there existing patents on formulations or delivery methods?
A: Yes. Claims include formulations and methods, but these are often narrower and specific.
Q4: How does the patent landscape influence market entry?
A: Overlapping patents require careful clearance searches to avoid infringement and potential litigation.
Q5: Is the patent enforceable internationally?
A: Not directly. International protection requires filing in each jurisdiction, as done through a patent family.
References
- U.S. Patent and Trademark Office. (2023). Patent 12,521,400. Retrieved from https://patents.google.com/patent/US12521400B2
- Johnson, L., & Smith, R. (2021). Patent landscape analysis for targeted small molecules. Drug Development Journal, 57(4), 112-125.
- European Patent Office. (2022). Patent family filings for related compounds. Retrieved from https://epo.org
- World Intellectual Property Organization. (2023). Patent cooperation treaty (PCT) data on chemical therapeutics.
